Nicotinic Receptors, Amyloid-β, and Synaptic Failure in Alzheimer's Disease

被引:50
作者
Juergensen, Sofia [1 ]
Ferreira, Sergio T. [1 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, Brazil
关键词
Alzheimer's disease; Nicotinic receptors; Amyloid-beta; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; SOLUBLE-PROTEIN OLIGOMERS; REGION IN-VIVO; ACETYLCHOLINE-RECEPTORS; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; NMDA RECEPTOR; BETA-AMYLOID(1-42) PEPTIDE; CHOLINESTERASE-INHIBITORS;
D O I
10.1007/s12031-009-9237-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dysfunctional cholinergic transmission is thought to underlie, at least in part, memory impairment and cognitive deficits in Alzheimer's disease (AD). However, it is still unclear whether this is a consequence of the loss of cholinergic neurons and elimination of nicotinic acetycholine receptors (nAChRs) in AD brain or of a direct impact of molecular interactions of the amyloid-beta (A beta) peptide with nAChRs, leading to dysregulation of receptor function. This review examines recent progress in our understanding of the roles of nicotinic receptors in mechanisms of synaptic plasticity, molecular interactions of A beta with nAChRs, and how A beta-induced dysregulation of nicotinic receptor function may underlie synaptic failure in AD.
引用
收藏
页码:221 / 229
页数:9
相关论文
共 50 条
  • [21] Cerebral Serotonin 4 Receptors and Amyloid-β in Early Alzheimer's Disease
    Madsen, Karine
    Neumann, Wolf-Julian
    Holst, Klaus
    Marner, Lisbeth
    Haahr, Mette Thorlund
    Lehel, Szabolcs
    Knudsen, Gitte Moos
    Hasselbalch, Steen Gregers
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 (03) : 457 - 466
  • [22] Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
    Pereira, Joana B.
    Janelidze, Shorena
    Ossenkoppele, Rik
    Kvartsberg, Hlin
    Brinkmalm, Ann
    Mattsson-Carlgren, Niklas
    Stomrud, Erik
    Smith, Ruben
    Zetterberg, Henrik
    Blennow, Kaj
    Hansson, Oskar
    BRAIN, 2021, 144 : 310 - 324
  • [24] Metals and amyloid-β in Alzheimer's disease
    Maynard, CJ
    Bush, AI
    Masters, CL
    Cappai, R
    Li, QX
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (03) : 147 - 159
  • [25] Alzheimer's Disease and the Amyloid-β Peptide
    Murphy, M. Paul
    LeVine, Harry, III
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 311 - 323
  • [26] Monocytes in the Peripheral Clearance of Amyloid-β and Alzheimer's Disease
    Guo, Huifang
    Zhao, Zhaohua
    Zhang, Ruisan
    Chen, Peng
    Zhang, Xiaohua
    Cheng, Fan
    Gou, Xingchun
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (04) : 1391 - 1400
  • [27] Amyloid-β oligomers in cellular models of Alzheimer's disease
    Fontana, Igor C.
    Zimmer, Aline R.
    Rocha, Andreia S.
    Gosmann, Grace
    Souza, Diogo O.
    Lourenco, Mychael, V
    Ferreira, Sergio T.
    Zimmer, Eduardo R.
    JOURNAL OF NEUROCHEMISTRY, 2020, 155 (04) : 348 - 369
  • [28] Alzheimer's disease amyloid-β pathology in the lens of the eye
    Moncaster, Juliet A.
    Moir, Robert D.
    Burton, Mark A.
    Chadwick, Oliver
    Minaeva, Olga
    Alvarez, Victor E.
    Ericsson, Maria
    Clark, John I.
    McKee, Ann C.
    Tanzi, Rudolph E.
    Goldstein, Lee E.
    EXPERIMENTAL EYE RESEARCH, 2022, 221
  • [29] Targeted proteomics in Alzheimer's disease:: focus on amyloid-β
    Portelius, Erik
    Zetterberg, Henrik
    Gobom, Johan
    Andreasson, Ulf
    Blennow, Kaj
    EXPERT REVIEW OF PROTEOMICS, 2008, 5 (02) : 225 - 237
  • [30] Pathological Changes Induced by Amyloid-β in Alzheimer's Disease
    Takata, Kazuyuki
    Kitamura, Yoshihisa
    Taniguchi, Takashi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (01): : 3 - 11